Remove 2027 Remove Public Health Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding public health.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

Establishing a Program for the Union’s Action in the Field of Health (EU4Health Programme) for the Period of 2021-2027, Regulation (EU) 2021/522, 24 March 2021. Regulation (EU) 2021/522 establishes a new and reinforced program for the Union’s action in the field of health, called the EU4Health Programme , for the period of 2021-2027.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.